As of Jun 29
| -0.26 / -4.91%|
The 1 analysts offering 12-month price forecasts for Ocata Therapeutics Inc have a median target of 16.00, with a high estimate of 16.00 and a low estimate of 16.00. The median estimate represents a +217.46% increase from the last price of 5.04.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.